Compare Stocks → One trade. One ticker. One week. (From Wealthpin Pro) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:HSAQNASDAQ:KRMDNASDAQ:LMAONASDAQ:TELA Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHSAQHealth Sciences Acquisitions Co. 2$4.52+0.4%$5.56$9.41▼$13.80$50.68M0.09205,918 shs29,371 shsKRMDKORU Medical Systems$2.23+4.2%$2.19$1.98▼$4.48$101.93M0.5394,256 shs4,865 shsLMAOLMF Acquisition Opportunities$12.35$10.83$5.72▼$22.00$140.05M-0.0150,946 shs560,236 shsTELATELA Bio$4.44-0.7%$5.82$4.23▼$11.26$109.45M0.95134,054 shs16,115 shs10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHSAQHealth Sciences Acquisitions Co. 2-2.59%-3.00%-14.07%-51.97%-67.69%KRMDKORU Medical Systems+0.47%-0.47%+1.90%+1.42%-47.80%LMAOLMF Acquisition Opportunities0.00%0.00%0.00%0.00%0.00%TELATELA Bio-2.19%-10.06%-21.99%-36.60%-52.75%Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot NowMarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationHSAQHealth Sciences Acquisitions Co. 2N/AN/AN/AN/AN/AN/AN/AN/AKRMDKORU Medical Systems1.9012 of 5 stars3.51.00.00.02.32.50.6LMAOLMF Acquisition OpportunitiesN/AN/AN/AN/AN/AN/AN/AN/ATELATELA Bio1.9138 of 5 stars3.52.00.00.02.21.70.6Analyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceHSAQHealth Sciences Acquisitions Co. 2N/AN/AN/AN/AKRMDKORU Medical Systems3.00Buy$3.5056.95% UpsideLMAOLMF Acquisition OpportunitiesN/AN/AN/AN/ATELATELA Bio3.00Buy$13.67207.81% UpsideCurrent Analyst RatingsLatest TELA, LMAO, HSAQ, and KRMD Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/22/2024TELATELA BioJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$15.003/22/2024TELATELA BioPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$15.00 ➝ $12.003/14/2024KRMDKORU Medical SystemsB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$4.00(Data available from 4/24/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookHSAQHealth Sciences Acquisitions Co. 2N/AN/AN/AN/A($0.62) per shareN/AKRMDKORU Medical Systems$28.52M3.57N/AN/A$0.45 per share4.96LMAOLMF Acquisition OpportunitiesN/AN/AN/AN/A($0.93) per shareN/ATELATELA Bio$58.45M1.87N/AN/A$0.77 per share5.77Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateHSAQHealth Sciences Acquisitions Co. 2-$380KN/A0.00∞N/AN/AN/A-2.38%N/AKRMDKORU Medical Systems-$13.74M-$0.29N/AN/AN/A-48.18%-27.82%-21.30%5/1/2024 (Confirmed)LMAOLMF Acquisition Opportunities$80KN/A0.00∞N/AN/A-44.29%3.70%N/ATELATELA Bio-$46.66M-$2.07N/AN/AN/A-79.83%-201.62%-58.60%5/9/2024 (Estimated)Latest TELA, LMAO, HSAQ, and KRMD EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/1/2024N/AKRMDKORU Medical Systems-$0.04N/A+$0.04N/AN/AN/A 3/21/2024Q4 2023TELATELA Bio-$0.44-$0.53-$0.09-$0.53$16.65 million$17.00 million3/13/2024Q4 2023KRMDKORU Medical Systems-$0.04-$0.02+$0.02$0.12$7.01 million$7.19 millionDividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthHSAQHealth Sciences Acquisitions Co. 2N/AN/AN/AN/AN/AKRMDKORU Medical SystemsN/AN/AN/AN/AN/ALMAOLMF Acquisition OpportunitiesN/AN/AN/AN/AN/ATELATELA BioN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioHSAQHealth Sciences Acquisitions Co. 2N/A0.170.61KRMDKORU Medical Systems0.024.553.77LMAOLMF Acquisition OpportunitiesN/A14.3514.35TELATELA Bio2.154.233.45OwnershipInstitutional OwnershipCompanyInstitutional OwnershipHSAQHealth Sciences Acquisitions Co. 289.71%KRMDKORU Medical Systems58.60%LMAOLMF Acquisition Opportunities85.03%TELATELA Bio94.35%Insider OwnershipCompanyInsider OwnershipHSAQHealth Sciences Acquisitions Co. 221.90%KRMDKORU Medical Systems21.70%LMAOLMF Acquisition OpportunitiesN/ATELATELA Bio5.70%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableHSAQHealth Sciences Acquisitions Co. 2411.21 million8.76 millionNot OptionableKRMDKORU Medical Systems8245.71 million35.79 millionOptionableLMAOLMF Acquisition OpportunitiesN/A11.34 millionN/ANot OptionableTELATELA Bio22724.65 million23.25 millionOptionableTELA, LMAO, HSAQ, and KRMD HeadlinesSourceHeadlineTELA Bio Launches Innovative Hernia Repair Device in the U.S. Marketmsn.com - April 17 at 9:16 AMTELA Bio launches OviTex IHR for inguinal hernia repair in USmsn.com - April 16 at 5:32 PMTELA Bio announces US launch OviTex IHR for use in laparoscopic and robotic-assisted inguinal hernia repairpharmabiz.com - April 16 at 7:29 AMTELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal Hernia Proceduresglobenewswire.com - April 15 at 7:00 AMMDXG: Legal Avenuesfinance.yahoo.com - April 11 at 1:10 PMTELA Bio Appoints Esteemed Surgeon Dr. Howard N. Langstein as Vice President of Medical Affairsmsn.com - April 10 at 6:58 AMTELA Bio, Inc.: TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategyfinanznachrichten.de - April 8 at 4:17 PMTELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategyglobenewswire.com - April 8 at 7:00 AMTELA Bio Stands Tall With Consistent Growth, Novel Products, and a Promising Revenue Projection for 2024msn.com - March 25 at 8:23 AMAnalysts Are Updating Their TELA Bio, Inc. (NASDAQ:TELA) Estimates After Its Full-Year Resultsfinance.yahoo.com - March 24 at 5:22 PMTELA Bio, Inc. (TELA) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 23 at 11:14 PMTELA Bio Full Year 2023 Earnings: US$2.04 loss per share (vs US$2.72 loss in FY 2022)finance.yahoo.com - March 23 at 8:39 AMTELA Bio Announces U.S. Commercial Launch of LIQUIFIX(TM) - the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia Surgerystockhouse.com - March 22 at 5:36 PMTELA Bio, Inc. (NASDAQ:TELA) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 22 at 5:36 PMQ4 2023 TELA Bio Inc Earnings Callfinance.yahoo.com - March 22 at 7:36 AMRecap: TELA Bio Q4 Earningsbenzinga.com - March 21 at 9:14 PMTELA Stock Earnings: TELA Bio Misses EPS, Beats Revenue for Q4 2023msn.com - March 21 at 9:14 PMTELA Bio Inc Reports Robust Revenue Growth in Q4 and Full Year 2023finance.yahoo.com - March 21 at 9:14 PMTELA Bio, Inc. (TELA) Reports Q4 Loss, Tops Revenue Estimateszacks.com - March 21 at 6:31 PMStrategic Divestiture and Innovative Product Launch Fuel Buy Rating for TELA Biomarkets.businessinsider.com - March 21 at 4:13 PMTELA Bio Achieves Record Fourth Quarter and Full Year 2023 Revenues and Reports Complete Financial Resultsfinance.yahoo.com - March 21 at 4:13 PMTELA Bio Achieves Record Fourth Quarter and Full Year 2023 Revenues and Reports Complete Financial Resultsglobenewswire.com - March 21 at 4:05 PMTela Bio Announces Commercial Launch Of Liquifix Devices In U.S.markets.businessinsider.com - March 21 at 10:07 AMTELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia Surgeryglobenewswire.com - March 21 at 7:00 AMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsHealth Sciences Acquisitions Co. 2NASDAQ:HSAQHealth Sciences Acquisitions Corporation 2 does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or related business combination with one or more businesses in the biopharma and medical technology sectors in North America or Europe. Health Sciences Acquisitions Corporation 2 was incorporated in 2020 and is based in New York, New York.KORU Medical SystemsNASDAQ:KRMDKORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.LMF Acquisition OpportunitiesNASDAQ:LMAOLMF Acquisition Opportunities, Inc. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Tampa, Florida.TELA BioNASDAQ:TELATELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
